PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 7 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,000,000 | +2.9% | 5,000,000 | 0.0% | 0.10% | -36.5% |
| Q1 2021 | $4,857,000 | +2.8% | 5,000,000 | 0.0% | 0.16% | +7.4% |
| Q4 2020 | $4,727,000 | +3.5% | 5,000,000 | 0.0% | 0.15% | -21.7% |
| Q3 2020 | $4,566,000 | +0.7% | 5,000,000 | 0.0% | 0.19% | -25.0% |
| Q2 2020 | $4,533,000 | +1.8% | 5,000,000 | 0.0% | 0.25% | +11.5% |
| Q1 2020 | $4,452,000 | +2.5% | 5,000,000 | 0.0% | 0.23% | +56.9% |
| Q4 2019 | $4,345,000 | – | 5,000,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,914,000 | $22,064,000 | 0.88% |
| WHITEBOX ADVISORS LLC | 5,000,000 | $4,857,000 | 0.16% |
| ANGELO GORDON & CO., L.P. | 1,397,000 | $1,357,000 | 0.12% |
| UBS OCONNOR LLC | 8,000,000 | $7,840,000,000 | 0.11% |
| INGALLS & SNYDER LLC | 500,000 | $490,000 | 0.02% |
| CITIGROUP INC | 7,832,000 | $7,608,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |